Clik here to view.
Clik here to view.
Desktop Health™ Introduces the PrintRoll™ Rotating Build Platform for the...
BOSTON Desktop Health — the trusted production-grade medical 3D printing brand of Desktop Metal, Inc. (NYSE: DM) — today announced a breakthrough in bioprinting with the launch of PrintRoll™, an...
View ArticleClik here to view.
Qihan Biotech Appoints Naxin Yao to its Board of Directors
HANGZHOU, China Hangzhou Qihan Biotech Co., Ltd. (“Qihan” or “Qihan Biotech” or “the Company”), an industry leader in applying multiplexable genome editing technology to cell therapies and organ...
View ArticleClik here to view.
Anteris Technologies Announces First Successful Implantation of DurAVR™ THV...
BRISBANE, Australia & MINNEAPOLIS Anteris Technologies Ltd, (Anteris or the Company) (ASX: AVR), a structural heart company developing DurAVR™ THV, a new class of biomimetic heart valve and the...
View ArticleClik here to view.
PHC株式会社と株式会社サイフューズが、再生・細胞医療分野での業務提携に関する基本合意を締結
東京 （ビジネスワイヤ） — PHCホールディングス株式会社（本社：東京都港区）傘下のPHC株式会社（本社：東京都港区、代表取締役社長：中村 伸朗、以下「PHC」）と、株式会社サイフューズ（本社：東京都港区、代表取締役：秋枝 静香、以下「サイフューズ」）は、この度、戦略的パートナーシップの強化を目的とした業務提携に関する基本合意書を締結しましたので、お知らせいたします。...
View ArticleClik here to view.
Anteris Technologies Commences US Early Feasibility Study
BRISBANE, Australia & MINNEAPOLIS Anteris Technologies Ltd, (Anteris or the Company) (ASX: AVR, OTC: ANTTY) reported today that DurAVR™ Transcatheter Heart Valve (THV), a new class of biomimetic...
View ArticleClik here to view.
Propanc Biopharma Targets Site of First-In-Human Study for PRP at the Peter...
MELBOURNE, Australia Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and...
View ArticleClik here to view.
Vergent Bioscience to Present Phase 2 Clinical Data for VGT-309 at IASLC 2023...
MINNEAPOLIS Vergent Bioscience, a clinical-stage biotechnology company developing tumor-targeted imaging agents, and its wholly owned subsidiary Vergent Bioscience Australia Pty Ltd, announced that...
View ArticleClik here to view.
New Study Evaluates the Use of Masimo PVi® As an Indicator of Fluid...
NEUCHATEL, Switzerland Masimo (NASDAQ: MASI) today announced the findings of a prospective, randomized study published in Perioperative Medicine in which Dr. Yu Wang and colleagues at institutions...
View ArticleClik here to view.
新研究评估Masimo PVi®在指导接受胃肠手术的老年患者进行目标导向液体治疗中作为液体反应性指标的使用情况
瑞士纳沙泰尔 (美国商业资讯)– Masimo (NASDAQ: MASI) 今天宣布在Perioperative Medicine（《围手术期医学》）发表的一项前瞻性随机研究的结果，其中Yu Wang博士及其来自中国深圳、韶关和广州医疗机构的同事通过与传统液体疗法进行比较，评估了无创、连续Masimo...
View ArticleClik here to view.
高齢患者の消化管手術における目標指向型輸液療法の輸液反応性の指標として、Masimo PVi®の使用を評価する新たな試験
スイス、ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は、Perioperative Medicineに掲載された非侵襲的、かつ連続的なMasimo PVi®...
View ArticleClik here to view.
Rapid Medical™ Gains Approval in China for the World’s Only Adjustable...
YOKNEAM, Israel & MIAMI Rapid Medical™, a leading developer of advanced neurovascular devices, announced Chinese approval for its TIGERTRIEVER revascularization device. With this milestone of...
View ArticleClik here to view.
MMI进军亚太市场，扩大全球足迹
佛罗里达州杰克逊维尔 (美国商业资讯)– 致力于增加复杂疾病患者的治疗选择和改善临床结果的机器人公司MMI（Medical Microinstruments, Inc.）今天宣布，它将会继续其全球发展势头，达成两项分销协议，覆盖亚太地区近十几个国家。这次与Device...
View ArticleClik here to view.
Avania Bolsters MedTech CRO Value Chain Capabilities With Two Acquisitions in...
BILTHOVEN, Netherlands Avania, a leading, global medical technology contract research organization (CRO), today announced its acquisition of HULL ASSOCIATES LLC and Ironstone Product Development...
View ArticleClik here to view.
Avania在工程设计、产品开发和市场准入等高度战略性领域进行了两次收购，增强了MedTech CRO的价值链能力
荷兰BILTHOVEN (美国商业资讯)– 领先的全球医疗技术合同研究组织（contract research organization，CRO）Avania今天宣布收购HULL ASSOCIATES LLC和Ironstone Product...
View ArticleClik here to view.
TaCa Healthcare is Revolutionizing the Healthcare Industry by Making Elective...
LONDON Founded by Bidhan Chowdhury and Abhinav Sharma, this healthcare startup has developed an innovative model that significantly reduces the cost of elective surgeries, making them more...
View ArticleClik here to view.
アバニア、エンジニアリング設計・製品開発および市場参入における戦略性の高い分野で2件の買収を行い、医療技術のCROバリューチェーン能力を強化
オランダ・ビルトホーフェン （ビジネスワイヤ） — 世界有数の医療技術開発業務受託機関（CRO）であるアバニアは、医療技術の規制と償還における新しい優先事項に対処し、すべての製品カテゴリーで思慮深い戦略と差別化されたプロジェクトの供給を行えるスケールを構築すべく、ハル・アソシエイツLLCおよびアイアンストーン製品開発（IPD）を買収したことを発表します。...
View ArticleClik here to view.
日本の神谷町脳神経外科クリニック、ZAP-X®ジャイロスコープラジオサージェリー®プラットフォームで脳腫瘍患者様の治療を開始
カリフォルニア州サンカルロス （ビジネスワイヤ） —...
View ArticleClik here to view.
Kamiyacho Neurosurgical Clinic in Japan Celebrates First Brain Tumor Patient...
SAN CARLOS, Calif. ZAP Surgical, a leading innovator in the field of surgical robotics, today announced the first patient treatment using the groundbreaking ZAP-X® Gyroscopic Radiosurgery® platform...
View ArticleClik here to view.
Glycologix Treats First Patient in Pilot Study of GLX-100 for Treatment of...
BEVERLY, Mass. & MELBOURNE, Australia Glycologix, Inc. (“Glycologix”), a clinical-stage company focused on developing biopolymers for the protection and repair of soft tissues, today announced...
View Article